The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level: a randomized, placebo-controlled study (Q82636190)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 November 2011

Language	Label	Description	Also known as
English	The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level: a randomized, placebo-controlled study	scientific article published on 13 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level: a randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lyudmila G Vladimirova-Kitova

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tanya I Deneva-Koycheva

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

13 November 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Vascular Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

56

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

122-130

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Association of asymmetric dimethylarginine and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

The cardioprotective effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Arginine and endothelial and vascular health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Burden : Writing Group III

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Statin safety: lessons from new drug applications for marketed statins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

ADMA increases arterial stiffness and decreases cerebral blood flow in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Statin safety: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Short term fluvastatin treatment lowers serum asymmetric dimethylarginine levels in patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.10.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2011.10.004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22108444%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82636190&oldid=1728875751"